Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Leica, Galena to develop companion diagnostic for breast cancer therapeutic
As part of the partnership, Leica’s Bond Oracle HER2 IHC System companion diagnostic will be used in choosing eligible patients for the NeuVax phase 3 PRESENT (Prevention of
As part of the partnership, Leica’s Bond Oracle HER2 IHC System companion diagnostic will be used in choosing eligible patients for the NeuVax phase 3 PRESENT (Prevention of
The patented MidNite works naturally to allow the usual sleep cycle to take over and contains a complex of natural herbs in addition to identical substances produced by
Pursuant to the deal signed between the two companies, Dr. Reddy’s has exclusive commercialization rights for the product, which will be exported from Debio Recherche Pharmaceutique, in India.
Australian Health Authorities approved the live-attenuated JE vaccine for people aged 12 months and older, based on data from clinical studies demonstrating the safety and efficacy of IMOJEV.
The trial focuses on Reparixin’s oral administration in combination with paclitaxel in women with metastatic breast cancer. The completed second cohort, in which patients were not limited to
COTI will look after the discovery, profiling and optimization activities of the drug candidates. Under the two step approach, COTI will identify and deliver early set of compounds
The new facility will provide the additional space needed for Impact Analytical as well as safe, efficient and accurate analysis of customer samples. Impact Analytical business manager Eric
OMS824 was well tolerated in the SAD study in which expected pharmacological effects were established in healthy subjects. The trial was designed to assess the multiple-dose administration of
Under the collaboration, Lilly will in-license a portfolio of branded generic injectable and oral cancer medicines from Agila Specialties, the specialties division of Strides Arcolab based in Bangalore,
The annual general meeting held on 17 October 2012, has approved the acquisition of 100% of the shares of X-Pol by way of a capital increase against contribution